The use of laser therapy in retinal diseases. Part III Review article
Article Sidebar
Main Article Content
Abstract
Retinal diseases account for the vast majority of ophthalmologic disorders. Over the past years, laser-based approach has been successfully used. Despite introduction of other potentially innovative, beneficial and successful therapeutic methods, lasers are still considered the gold standard. In this review, we discuss the spectrum of currently prevailing laser methods and new insights into novel perspectives and techniques regarding laser management of retinal disorders. This paper is divided into three sections. Two parts, already published in previous issues, have presented methodology with the spectrum of laser-based techniques and literature review investigating the existing knowledge in laser management of diabetic retinopathy, diabetic macular edema and vascular retinal disorders. Finally, the current one, consists of the principles guiding laser treatment of retinal tears, retinal degeneration, retinopathy of prematurity, age-related macular degeneration and other retinal diseases.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: © Medical Education sp. z o.o. License allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
2. Shah PK, Prabhu V, Karandikar SS et al. Retinopathy of prematurity: past, present and future. World J Clin Pediatr. 2016; 5: 35-46.
3. Solebo Al, Teoh L, Rahi J. Epidemiology of blindness in children. Arch Dis Child. 2017; 102(9): 853-7.
4. Seiberth V, Linderkamp O. Risk factors in retinopathy of prematurity. A multivariate statistical analysis. Ophtalmologica 2000; 214: 131-5.
5. Bowling B. Kanski Okulistyka Kliniczna. 8th ed. Urban&Partner, Wrocław 2017: 506-8, 520-556, 561-9, 603-4, 615-7, 623-630, 681-700, 797-8.
6. International Committee for the Classification of Retinopathy of Prematurity. The International Classsification of Retinopathy of Prematurity revisted. Arch Ophtalmol. 2005; 123(7): 991-9.
7. Chiang M, Arons R, Flynn JT et al. Incidence of retinopathy of prematurity from 1966 to 2000: analysis of a comprehensive New York state database. Ophthalmology. 2004; 111: 1317-25.
8. Zespół Ekspertów Sekcji Okulistyki Dziecięcej Polskiego Towarzystwa Okulistycznego. Postępowanie w retinopatii wcześniaków – wytyczne PTO.
9. Kara C, Petricli IS, Hekimoglu E et al. Treatment success of laser therapy for retinopathy of prematurity in referred and non-refered patients. Arq Bras Oftalmol. 2016; 79: 96-9.
10. Ng EY, Connolly BP, McNamara JA et al. A comparison of laser photocoagulation with cryotheraphy for threshold retinopathy of prematurity AT 10 years: part 1. Visual function and structuraloutcome. Ophtalmology. 2002; 109: 928-34.
11. White JE, Repka MX. Randomized comparison of diode laser coagulation versus cryotherapy for threshold retinopathy of prematurity: 3-year outcome. J Pediatr Ophtalmol Strabismus. 1997; 34: 83-7.
12. Shalev B, Farr AK, Repka MX. Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: seven-year outcome. Am J Ophthalmol. 2001; 132: 76-80.
13. Zwyrodnienie plamki związane z wiekiem. Przewodnik postępowania na podstawie The Royal College of Ophtalmologists 2015.
14. Wu Q, Liu B, Yuan L et al. Dysregulations of follicular helper T cells through IL-21 pathway in age-related macular degeneration. Mol Immunol. 2019; 114: 243-50.
15. Guymer RH, Wu Z, Hodgson LAB et al. Subthreshold Nanosecond Laser Intervention in Age-Related Macular Degeneration: The LEAD Randomized Controlled Clinical Trial. Laser Intervention in EarlyStages of Age-Related Macular Degeneration Study Group. Ophthalmology. 2019; 126(6): 829-38.
16. Lek JJ, Brassington KH, Luu CD et al. Subthreshold Nanosecond Laser Intervention in Intermediate Age-Related Macular Degeneration: Study Design and Baseline Characteristics of the Laser in Early Stages of Age-Related Macular Degeneration Study (Report Number 1). Ophthalmol Retina. 2017; 1(3): 227-239.
17. Smith RT. Sub-threshold nanosecond laser (SNL) treatment in intermediate AMD (IAMD). Ann Eye Sci. 2019; 4: 2.
18. Wu Z, Luu CD, Hodgson LAB et al. Secondary and Exploratory Outcomes of the Subthreshold Nanosecond Laser Intervention Randomized Trial in Age-Related Macular Degeneration: A LEAD Study Report. Ophthalmol Retina. 2019; 3(12): 1026-34.
19. Tesla P. Zespół oderwania siatkówki (zwyrodnienia obwodu siatkówki predysponujące do odwarstwienia siatkówki). Okul Dypl. 2018; 8(2): 46-9.
20. Kaczmarek R, Misiuk-Hojło M, Wykrota H. Terapia laserowa w chorobach siatkówki niezwiązanych z cukrzycą. Górnicki Wydawnictwo Medyczne, Wrocław 2009: 2-6, 34-40, 44-62, 78-90.
21. Zhang Y, Liu S, Lee V. Re: Prophylactic treatment of retinal break – a systematic review. Acta Ophtalmol. 2016; 94(1): e77.
22. Ripandelli G, Rossi T, Cacciamani A et al. Laser prophylactic treatment of the fellow eye in giant retinal tears: long-term follow-up. Retina. 2016; 36(5): 962-6.
23. Manyś-Kubacka K, Kocięcki J. Profilaktyka odwarstwienia siatkówki. Okulistyka. 2001; 1.
24. Lewis H. Peripheral retinal degenerations and the risk of retinal detachment. Am J Ophthalmol. 2003; 136(1): 155-60.
25. Maltsev D, Kulikov A, Uplanchiwar B et al. Direct navigated laser photocoagulation as primary treatment for retinal arteria macroaneurysms. Int J Retina Vitreous. 2018; 4: 28.
26. Ramel J. Treatment of macroaneurisms in macular oedema: Navigated laser Leeds the next generation of photocoagulation therapy. Ophthalmology Times. 2018; 14(10): 27.